Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular genetics of colorectal cancer.

Literature DB >> 8526339

Molecular genetics of colorectal cancer.

E R Fearon¹.

Abstract

Entities: Disease

Mesh：

Year: 1995 PMID： 8526339 DOI： 10.1111/j.1749-6632.1995.tb12114.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.

Authors: Mark L McCleland; Kathryn Mesh; Edward Lorenzana; Vivek S Chopra; Ehud Segal; Colin Watanabe; Benjamin Haley; Oleg Mayba; Murat Yaylaoglu; Florian Gnad; Ron Firestein
Journal: J Clin Invest Date: 2016-01-11 Impact factor: 14.808

2. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma.

Authors: Hanlee Ji; Jochen Kumm; Michael Zhang; Kyle Farnam; Keyan Salari; Malek Faham; James M Ford; Ronald W Davis
Journal: Cancer Res Date: 2006-08-15 Impact factor: 12.701

3. Role of matrix metalloproteinases in colorectal carcinogenesis.

Authors: M J Heslin; J Yan; M R Johnson; H Weiss; R B Diasio; M M Urist
Journal: Ann Surg Date: 2001-06 Impact factor: 12.969

4. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.

Authors: Ming Yu; William M Grady
Journal: Therap Adv Gastroenterol Date: 2012-09 Impact factor: 4.409

5. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.

Authors: T J Koh; C J Bulitta; J V Fleming; G J Dockray; A Varro; T C Wang
Journal: J Clin Invest Date: 2000-08 Impact factor: 14.808

6. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.

Authors: Barbara Mroczko; Magdalena Groblewska; Bogna Okulczyk; Bogusław Kedra; Maciej Szmitkowski
Journal: Int J Colorectal Dis Date: 2010-06-17 Impact factor: 2.571

Molecular genetics of colorectal cancer.

1. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.

2. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma.

3. Role of matrix metalloproteinases in colorectal carcinogenesis.

4. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.

5. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.

6. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.

7. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer.

8. Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma.

Review 9. Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature.

10. Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer.